Loading...

Thursday, February 18th



Miguel Martín, Hospital General Universitario Gregorio Marañón, Madrid, Spain
Chair:
Luis Marqués da Costa, Hospital de Santa María, Lisbon, Portugal
16:15 - 16:35Chronology of breast cancer metastases
Christina Curtis, Stanford University, California, USA
16:35 - 16:55Exercise and immunometabolic regulation in cáncer
Lee Jones, Memorial Sloan Kettering Cancer Center, New York, USA
16:55 - 17:15Mechanisms of resistance to CDK 4/6 inhibitors
Mitchell Dowsett, The Royal Marsden Hospital and The Institute of Cancer Research, London, UK
17:15 - 17:45Discussion
Chair:
José Enrique Alés, Hospital Ntra. Sra. de Sonsoles, Ávila, Spain
18:00 - 18:20Does axillary lymph node dissection improve survival of node-positive operable breast cancer in the 21st century?
Terry Mamounas, Orlando Health Cancer Institute, Orlando, USA
18:20 - 18:40HER2+ Early Breast Cancer - Current Adjuvant Therapies and Promising Agents on the Horizon
Miguel Martín, Hospital General Universitario Gregorio Marañón, Madrid, Spain
18:40 - 19:00CDK 4/6 inhibitors in breast cancer: from the bench to the bedsite
Richard Finn, University of California, Los Angeles, USA
19:00 - 19:30Discussion